Table 2.
Total (n = 563) | Men (n = 456) | Women (n = 107) | p | |
---|---|---|---|---|
LVEDD (mean ± SD), cm | 5.25 ± 0.62 | 5.31 ± 0.63 | 5 ± 0.47 | < 0.001 |
LVEF (mean ± SD) | 0.6 ± 0.11 | 0.59 ± 0.1 | 0.61 ± 0.11 | 0.359 |
FS (mean ± SD) | 0.32 ± 0.07 | 0.32 ± 0.07 | 0.33 ± 0.07 | 0.242 |
Target CTO vessel, n (%) | 0.816 | |||
LAD | 157 (27.9) | 131 (28.7) | 26 (24.3) | |
LCX | 143 (25.4) | 114 (25) | 29 (27.1) | |
RCA | 206 (36.6) | 166 (36.4) | 40 (37.4) | |
≥2 vessel | 57 (10.1) | 45 (9.9) | 12 (11.2) | |
ISR | 37 (6.6) | 26 (5.7) | 11 (10.3) | 0.085 |
Three-vessel disease | 523 (92.9) | 423 (92.8) | 100 (93.5) | 0.801 |
LM disease | 107 (19) | 86 (18.9) | 21 (19.6) | 0.856 |
CTO revascularization | 300 (53.3) | 248 (54.4) | 52 (48.6) | 0.28 |
Values are n (%), mean ± SD, or median with interquartile range
LVEDD left ventricular end-diastolic dimension, LVEF left ventricular ejection fraction, FS fraction shortening, LAD left anterior descending coronary artery, LCX left circumflex coronary artery, RCA right coronary artery disease, ISR in-stent restenosis, LM disease left main coronary artery disease